(Q42999099)

English

Efficient immunization of rhesus macaques with an HCV candidate vaccine by heterologous priming-boosting with novel adenoviral vectors based on different serotypes

scientific article published on 23 March 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

12 November 2017

Efficient immunization of rhesus macaques with an HCV candidate vaccine by heterologous priming-boosting with novel adenoviral vectors based on different serotypes (English)

1 reference

Europe PubMed Central

12 November 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Fattori E

1

1 reference

Europe PubMed Central

12 November 2017

Zampaglione I

2

1 reference

Europe PubMed Central

12 November 2017

Arcuri M

3

1 reference

Europe PubMed Central

12 November 2017

Meola A

4

1 reference

Europe PubMed Central

12 November 2017

Ercole BB

5

1 reference

Europe PubMed Central

12 November 2017

Cirillo A

6

1 reference

Europe PubMed Central

12 November 2017

Folgori A

7

1 reference

Europe PubMed Central

12 November 2017

Bett A

8

1 reference

Europe PubMed Central

12 November 2017

Cappelletti M

9

1 reference

Europe PubMed Central

12 November 2017

Sporeno E

10

1 reference

Europe PubMed Central

12 November 2017

Cortese R

11

1 reference

Europe PubMed Central

12 November 2017

Nicosia A

12

1 reference

Europe PubMed Central

12 November 2017

Colloca S

13

1 reference

Europe PubMed Central

12 November 2017

publication date

23 March 2006

1 reference

Europe PubMed Central

12 November 2017

1 reference

Europe PubMed Central

12 November 2017

13

1 reference

Europe PubMed Central

12 November 2017

14

1 reference

Europe PubMed Central

12 November 2017

1088-1096

1 reference

Europe PubMed Central

12 November 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3302754

0 references

Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

21 January 2018

Adenoviruses as vaccine vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

21 January 2018

Heterologous human immunodeficiency virus type 1 priming-boosting immunization strategies involving replication-defective adenovirus and poxvirus vaccine vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

21 January 2018

A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

21 January 2018

Induction of CD8+ T cells to an HIV-1 antigen through a prime boost regimen with heterologous E1-deleted adenoviral vaccine carriers.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

21 January 2018

Characterization of a family of chimpanzee adenoviruses and development of molecular clones for gene transfer vectors.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

21 January 2018

Adenovirus types 5 and 35 seroprevalence in AIDS risk groups supports type 35 as a vaccine vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

21 January 2018

Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

21 January 2018

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

21 January 2018

Development of stable liquid formulations for adenovirus-based vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

21 January 2018

Human immunodeficiency virus type 1-specific immune responses in primates upon sequential immunization with adenoviral vaccine carriers of human and simian serotypes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

21 January 2018

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

21 January 2018

An effective AIDS vaccine based on live attenuated vesicular stomatitis virus recombinants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

21 January 2018

Comparative Immunogenicity in Rhesus Monkeys of DNA Plasmid, Recombinant Vaccinia Virus, and Replication-Defective Adenovirus Vectors Expressing a Human Immunodeficiency Virus Type 1 gag Gene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

21 January 2018

Multispecific T cell response and negative HCV RNA tests during acute HCV infection are early prognostic factors of spontaneous clearance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

21 January 2018

Analysis of a successful immune response against hepatitis C virus

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

21 January 2018

An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

21 January 2018

Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

21 January 2018

Enhancing B- and T-cell immune response to a hepatitis C virus E2 DNA vaccine by intramuscular electrical gene transfer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

21 January 2018

Gene therapy of cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

7 January 2021

based on heuristic

inferred from DOI database lookup

Early impairment of hepatitis C virus specific T cell proliferation during acute infection leads to failure of viral clearance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302754

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.GT.3302754

1 reference

Europe PubMed Central

12 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

12 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42999099&oldid=1976321117"